Parallax Volatility Advisers, L.P. Zymeworks Inc. Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.82 - $7.7 $144,600 - $231,000	30,000 New	30,000 $159,000
Q3 2018 Nov 14, 2018	SELL	$12.21 - $16.61 $13,431 - $18,271	-1,100 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$7.93 - $13.41 $4,758 - $8,046	-600 Reduced 35.29%	1,100 $13,000
Q4 2017 Feb 14, 2018	BUY	$6.87 - $9.19 $11,679 - $15,623	1,700	1,700 $13,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.